New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 21, 2023 - The FDA approved a label update to Janssen’s Carvykti (ciltacabtagene autoleucel), adding a Boxed Warning for secondary hematological malignancies.
Download PDF
Return to publications
